693 SQZ-AAC-HPV-101: initial data from a phase I dose escalation/expansion study of SQZ-AAC-HPV, a red blood cell-based therapeutic cancer vaccine for HPV16+ solid tumors

• Emese Zsiros,
• Anthony F Shields,
• Howard Bernstein,
• Scott Loughhead,
• Richard T Maziarz,
• Shivani Joshi,
• Julia Jennings,
• Nathan Miselis,
• Marshelle S Warren,
• Victoria Villaflor,
• Rajwanth Veluswamy

Affiliations

Emese Zsiros

3Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Anthony F Shields

12 Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA

Howard Bernstein

SQZ Biotechnologies, Watertown, MA, USA

Scott Loughhead

5SQZ Biotechnologies, Watertown, MA, USA

Richard T Maziarz

BMT & Cell Therapy Program, Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA

Shivani Joshi

General Surgery, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK

Julia Jennings

8SQZ Biotechnologies, Watertown, MA, USA

Nathan Miselis

10SQZ Biotechnologies, Watertown, MA, USA

Marshelle S Warren

10SQZ Biotechnologies, Watertown, MA, USA

Victoria Villaflor

5City of Hope, Duarte, CA, USA

Rajwanth Veluswamy

2Mount Sinai, New York, NY, USA